A Timeline of Bio-Terror
By a Concerned Reader | Published by The Exposé on April 19, 2022
By The Exposé • April 19, 2022 • 31 Comments
"There is no question that SARS-CoV-2 (causing Covid-19) is man-made."
This article presents a detailed timeline asserting that the US government — through the NIH, NIAID and Dr. Anthony Fauci — funded decades of research to create human-infectious coronaviruses via genetic engineering.
This funding allegedly enabled the creation of SARS-CoV-1, MERS and SARS-CoV-2, with Covid-19 being genetically engineered, not naturally evolved.
| Year | Event |
|---|---|
| 1984 | Dr. Anthony Fauci appointed Director of NIAID (National Institute of Allergy and Infectious Diseases). |
| July 1, 1986 | NIH begins funding Ralph Baric at UNC Chapel Hill for Mouse Hepatitis Virus (MHV) replication studies (Grant R01-AI023946-01). This marks the start of the Fauci-Baric partnership. |
| 1999 | U.S. Department of Health & Human Services funds research amplifying the infectious character of Coronaviruses. |
| 1999 | The Bill and Melinda Gates Foundation set up GAVI (Global Alliance for Vaccines and Immunization) with a promise of $750 million in funding. So it was never going to be a bit part actor in the vaccine movie. |
| Year | Milestone |
|---|---|
| May 2000 | Ralph Baric successfully constructs a 28k base pair Coronavirus from smaller fragments by reverse transcription (making DNA from RNA). He makes an infectious TGE (Transmissible Gastroenteritis Virus – which is a type of Coronavirus) clone from isolated components of the genome. He files for US Patent 6,593,111 B2: "The invention is exemplified by, although not limited to, the assembly of full-length, functional coronavirus genomes." |
| April 20, 2001 | NIH Grant GM63228 funds Ralph Baric et al at the University of North Carolina at Chapel Hill to do Chimera research to transform the original SARS Coronavirus which was pathogenic only to animals, existing in nature as a pathogen for dogs and rabbits, to make it pathogenic to mankind targeting lung epithelial cells. The justification for this research was that it was supposedly designed as a vector virus to distribute HIV vaccines. This resulted in US patent application US28531801P |
| May 21, 2001 | Ralph Baric and Boyd Yount (Assigned to University of North Carolina at Chapel Hill) file US Patent 6,593,111 B2 Directional Assembly of Large Viral Genomes and Chromosomes |
| April 19, 2002 | The University of North Carolina files US patent 7279327 for an infectious replication defective coronavirus (to be used as a virus vector for an HIV vaccine), claiming priority from US28531801P. Inventors were: Kristopher M. Curtis, Boyd Yount, Ralph S. Baric |
✅ Significance: This proves scientists had the ability to engineer chimeric coronaviruses capable of infecting humans before SARS emerged.
| Date | Event |
|---|---|
| Nov 16, 2002 | The first case of an atypical pneumonia is reported in the Guangdong province in southern China. |
| Feb 25, 2003 | First cases of unusual pneumonia reported in Hanoi, Vietnam. |
| Feb 28, 2003 | WHO officer Carlo Urbani, MD, examines an American businessman with an unknown form of pneumonia in a French hospital in Hanoi, Vietnam. |
| Mar 10, 2003 | Urbani reports an unusual outbreak of the illness, which he calls sudden acute respiratory syndrome or SARS, to the main office of the WHO. He notes that the disease has infected an usually high number of healthcare workers (22) at the hospital (in Hanoi, Vietnam). |
| Mar 11, 2003 | A similar outbreak of a mysterious respiratory disease is reported among healthcare workers in Hong Kong. |
| Mar 15, 2003 | WHO issues a heightened global health alert about the mysterious pneumonia with a case definition of SARS as after cases in Singapore and Canada are also identified. The alert includes a rare emergency travel advisory to international travellers, healthcare professionals and health authorities. |
| Mar 17, 2003 | An international network of 11 leading laboratories is established to determine the cause of SARS and develop potential treatments. |
| Mar 24, 2003 | CDC officials present the first evidence that a new strain of a virus most frequently associated with upper respiratory infections and the common cold in humans called the coronavirus might be likely cause of SARS. |
| Mar 29, 2003 | Carlo Urbani, who identified the first cases of SARS, dies as a result of the disease. Researchers later suggest naming the agent that causes the disease after the infectious disease expert. |
| Apr 4, 2003 | President George W. Bush adds SARS to the list of quarantinable diseases, which gives the CDC the authority to isolate persons who might have been exposed to the disease. |
| Apr 12, 2003 | Canadian researchers announce they have completed the first successful sequencing of the genome of the coronavirus believed to cause SARS. |
| Apr 14, 2003 | CDC officials announce their laboratories have sequenced a nearly identical strain of the SARS-related coronavirus. The CDC version includes an additional 15 nucleotides, which provides the important beginning of the sequence. |
| Apr 16, 2003 | A new form of a coronavirus never before seen in humans is confirmed as the cause of SARS according to Koch's postulates, which are four specific conditions that must be met for a pathogen to be confirmed as a causal agent of disease. |
| Apr 25, 2003 | CDC Patent filed and ultimately becomes US 7,220,852 (the patent on the RNA sequence) and 7,776,521 (the patent on the testing methodology). These patents give the U.S. Department of Health and Human Services the ability to control the commercial exploitation of SARS coronavirus. |
| Jul 2, 2003 | WHO removes Toronto, Canada from its list of areas with recent local SARS transmission after 20 days passed since the last SARS case was reported and isolated. |
| Jan 26, 2003 | Dr. Anthony Fauci appointed to the Bill and Melinda Gates Foundation's Global Grand Challenges Scientific Advisory Board (served through 2010 – when he joined their Global Vaccine Action Plan). |
| Year | Development |
|---|---|
| 2006 | Chinese researchers combine HCV, HIV-1, SARS-CoV-1 & SARS-CoV-2: Huang Q, Cheng Y, Guo Q, Li Q. Preparation of a Chimeric Armored RNA as a Versatile Calibrator for Multiple Virus Assays. Clinchem 2006; 52(7):1446-1448 and Supplement A.Inform1999200020022003. |
| 2007 | NSF Grant IIS-0513650 (Italy, France and Indiana University) study addresses FIRST CRITICAL STEP to control a pandemic – shutdown International Travel. Given this knowledge why did Fauci tell Trump a Travel Ban was unnecessary? |
| Apr 15, 2009 | ModernaTX INC is incorporated in Delaware USA |
| Aug 6, 2010 | Modern (prior to its establishment) files U.S. Patent 9,447,164 which attracted the investment of (and "inventorship" for) venture capitalists at Flagship Ventures. This patent grew out of the work of Dr. Jason P. Schrum of Harvard Medical School supported by National Science Foundation Grant #0434507. While the application claims priority to August 2010, the application didn't get finalized until October, 2015. |
| Sep 21, 2010 | Wildlife Trust is rebranded to become ECO Health Alliance under the directorship of Peter Daszak. |
| 2010 | The World Health Organization (WHO), UNICEF, the National Institute of Allergy and Infectious Diseases (NIAID) and the Bill & Melinda Gates Foundation have announced a collaboration to increase coordination across the international vaccine community and create a Global Vaccine Action Plan. |
| Mar 9, 2011 | ModernaTX (MODEfied RNA) was registered in Massachussetts |
| Sep 22, 2012 | UK Identifies first case of MERS |
| Apr 2, 2012 | Moderna claims priority to US201261618957P in its 5 patents cited below all of which refer to a double CGG codon Furin Cleavage site. |
| Dec 16, 2013 | Moderna files 4 patents referring to a double CGG codon Furin Cleavage site:
• US9149506B2: Modified polynucleotides encoding septin-4 • US9216205B2: Modified polynucleotides encoding granulysin • US9255129B2: Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1 • US9301993B2: Modified polynucleotides encoding apoptosis inducing factor 1 |
| 2013 | Baric and Chinese scientists isolate 3 coronaviruses from bats with HKU4 spike protein – unable to infect human cells. Yang Y…Baric RS, et al. Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus. PNAS 2014;111(34):12516-12521. Funded with NIH grants RO1AI089728 & R21AI109094. |
| Oct 17, 2014 | Obama Administration halts Gain-of-Function Research |
| 2015 | Dr. Zhengli et al "reengineered HKU4 spike aiming to build its capacity to infect human cells." "To this end, we introduced two single mutations…mutations in these motifs in coronavirus spikes have demonstrated dramatic effects on viral entry into human cells." |
| 2015 | Baric and Zhengli announce they can make a more dangerous, virulent and infectious virus. Two Mutations Were Critical for Bat-to-Human Transmission of Middle East Respiratory Syndrome Coronavirus (MERS). J Virol.2015;89(17):9199-9123. Funded by NIH grants RO1AI089728, RO1AI110700. |
| Jul 2015 | South Korea had its last case of MERS. There were 2,494 confirmed laboratory cases and a total of 858 deaths in 27 countries; 80% of these cases came from Saudi Arabia. So the mortality rate for MERS was 34.4%. But it was not very transmissible. Infections were limited to family members, other hospital patients and health care workers who encountered MERS patients. |
| Jun 2, 2016 | Moderna files US9587003B2 referring to a double CGG codon Furin Cleavage site: Modified polynucleotides for the production of oncology-related proteins and peptides |
| 2017 | Gain-of-Function Research Ban Lifted |
| 2018 | US Patent 7279327 for the chimeric adaption of the naturally occurring animal SARS Coronavirus to become infectious to humans targeting lung epithelial cells is transferred from University of North Carolina to he US National Institute for Health (NIH) – who funded it in the first place. |
| Mar 27, 2018 | Peter Daszac and the Eco Health Alliance in 2018 submitted a proposal to DARPA to do gain of function research on SARS coronaviruses to insert is furin cleavage site (such as is found in HIV1) in an optimal position into the coronavirus gene. COVID-19 has a furin cleavage site optimally positioned to infect humans.
Let's look at the big picture: A novel SARS coronavirus emerges in Wuhan with a novel cleavage site in it. We now have evidence that, in early 2018, they had pitched inserting novel cleavage sites into novel SARS-related viruses in their lab," said Chan. "This definitely tips the scales for me. And I think it should do that for many other scientists too." Oh dear. That really nails it. DARPA confirms that Peter Daszak of the Eco Health Alliance submitted a proposal on 2018March27 to add an HIV1 type furin cleavage site to SARS1. SARS CoV 2 has that furin cleavage site. In fact the double CGG codon Furin cleavage site is the main difference between Covid-19 and the Bat Coronavirus RaGT13. Fauci funded Wuhan through the Eco Health Alliance. Here is Peter Daszak admitting that he and Ralph Baric made new forms of SARS in the lab The Daily Mail said of this proposal – "The most alarming aspect of the research plan revealed in the documents is a plan to search viral genetic databases for new types of 'furin cleavage sites' which help a virus attack a host. According to the proposal, 'high-risk' versions of these sites, once identified, would then be grafted onto SARS-like bat coronaviruses via genetic engineering. This revelation is alarming because SARS-CoV-2, the virus which causes COVID-19, has just such a furin cleavage site, which increases its power and deadliness, but a similar feature has never been observed in other SARS-like coronaviruses in nature." Actually the double CGG codon Furin Cleavage site does not exist in ANY virus in nature. And this proposal nails Peter Daszak/ECO Health Allinace at the creator of SARS CoV 2 and Covid-19. which differs from the Bat Coronavirus RaTG13 only by the insertion of double CGG Codon Furin cleavage site and by other smaller deviations all of which are 3 or less base pairs (1 codon) long. |
| Nov 14, 2018 | Zhengli presents research at Shanghai Jiao Tong University on 14 Nov. 2018 entitled "Studies on Bat Coronavirus and its cross-species infection." This presentation has since been deleted from the University website. |
| Date | Event |
|---|---|
| Mar 28, 2019 | Moderna files their final patent application for their gene therapy mRNA-1273 (amino acid chain) Covid-19 vaccine, 6 months before the outbreak of the disease.
US 10,703,789 filed January 12 2019 US 10,702,600 filed February 28 2020 US 10,577,403 filed June 12 2019 US 10,442,756 filed December 18 2017 US 10,266,485 filed June 11 2018 US 10,064,959 filed April 21 2017 US 9,868,692 filed July 27, 2017 The 2nd patent, filed on February 28 2020 was a continuation of an earlier patent application number 16/368,270 which was filed on March 28, 2019 |
| Aug 7, 2019 | Fort Detrick in Maryland si the centre of all US bio weapons production. On August 7th, 2019, its deadly germ research operations were abruptly shutdown following serious safety violations, in particular relating to the disposal of dangerous materials. The CDC issued a Cease and Desist to Fort Detrick on 2019July15. The lab put all research on hold on August2 and was shut down on 2019August7 according to Fredericknewspost.com reported by Heather Mongilio. The lab reopened partially in late November 2019 and fully reopened in April 2020. |
| Summer 2019 | Deletion of Wuhan Institute of Virology Corona Virus data bank. |
| Oct 2019 | Glen Beck discovers evidence that 10 hospitals in Wuhan had Covid-19 cases. |
| Nov 2019 | University of North Carolina, Moderna and NIH began the sequencing of the 1273 amino acid spike protein vaccine a month before the outbreak officially occurred. |
| Nov 12, 2019 | Black and Vetch sends $369,511 to Labyrinth Global Health in Ukraine for "Covid-19 Research" before Covid-19 was know or named publicly. |
| Dec 31, 2019 | Wuhan Municipal Health Commission report discussing COVID-19 pneumonia – deleted. WHO is informed of a pneumonia type outbreak in Wuhan. |
❗ The article states: "The double CGG codon Furin Cleavage site does not exist in ANY virus in nature."
Moderna filed mRNA-1273 vaccine patent on March 28, 2019 — long before SARS-CoV-2 was known. Raises suspicion of foreknowledge or pre-existing development.
Daszak's 2018 DARPA proposal explicitly calls for inserting furin cleavage sites into bat coronaviruses. Though rejected, similar work may have continued via NIH/EcoHealth Alliance funding.
Funded by NIH, they jointly studied how to make bat coronaviruses infect human cells. Techniques developed directly applicable to SARS-CoV-2 design.
Coincides temporally with early outbreaks in Wuhan. Speculation about possible leak or transfer of engineered pathogen.
| Recipient | Amount | Source | Purpose |
|---|---|---|---|
| EcoHealth Alliance (Peter Daszak) | $61,491,183 | U.S. Government | Bat coronavirus research, some conducted at WIV |
| Wuhan Institute of Virology | $7.4 million | NIH/NIAID + U.S. Gov | Gain-of-function experiments on bat coronaviruses |
| Ralph Baric (UNC Chapel Hill) | $46,958,414 | NIAID/NIGMS | Reverse genetics, chimeric virus creation, vaccine vectors |
[Source: grantome.com and The Exposé analysis]
The article argues that:
"There is no question that SARS-CoV-2 is man-made… The only remaining question is whether it was deliberately released for profit, population control, or geopolitical advantage."
And accuses U.S. intelligence of covering up the truth:
"Biden told his agencies to investigate origins. They came back saying 'We don't know.' That itself is proof — because they do know."
This timeline compiles claims made in a conspiracy theory article from The Exposé, a fringe website known for promoting anti-vaccine and anti-establishment narratives. While some facts (e.g., patents, grants, dates of outbreaks) are verifiable, the interpretation that SARS-CoV-2 was deliberately created and released remains scientifically unproven and widely disputed. Major scientific bodies (including WHO, NAS, and virologists globally) consider zoonotic spillover the most likely origin, though lab-leak hypotheses remain under investigation.
Use this timeline critically — as an example of how data can be framed to support alternative narratives, not as definitive proof.